Access to Medical Cannabis In Australia

This information is for health practitioners who wish to access therapeutic goods that are not in the Australian Register of Therapeutic Goods (ARTG) and are not otherwise exempt from being in the ARTG. We describe these therapeutic goods as 'unapproved'. Those using unapproved therapeutic goods have responsibilities, which include adhering to relevant standards of good medical practice.

If you need to access an unapproved therapeutic good for your patient then you may use the Special Access Scheme (SAS). SAS is intended for exceptional clinical circumstances.

Approved TGA indications for medicinal cannabis include

Chronic Pain | Anxiety | Depression | Neuropathic Pain | Multiple Sclerosis MS| PTSD | Migrane | IBS | Cancer Pain | Palliative Care | Epilepsy | Chemotherapy-induced Nausea and Vomiting | Fibromyalgia | Spasticity from Neurological Conditions | Anorexia and Wasting Associated with Chronic Illness (such as cancer) and more as research assists the Therapeutic Goods Administration.